Hsyu PH[au] - Search Results

Year	Number of Results
1985	1
1986	1
1987	2
1988	3
1989	1
1991	1
1993	1
1994	6
1995	1
1996	1
1997	2
1998	1
1999	1
2001	1
2002	1
2005	1
2006	2
2007	1
2011	1
2012	3
2013	1
2014	1
2016	3
2017	4
2018	1
2019	1
2023	0

1

Retraction notice to "Population pharmacokinetic and pharmacodynamic analysis of bosutinib" [Drug Metab Pharmacokinet 29 (2014) 441-448].

Hsyu PH, Mould DR, Abbas R, Amantea M. Hsyu PH, et al. Drug Metab Pharmacokinet. 2019 Apr;34(2):163. doi: 10.1016/j.dmpk.2019.01.003. Epub 2019 Feb 10. Drug Metab Pharmacokinet. 2019. PMID: 30922682

2

Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib.

Abbas R, Hsyu PH. Abbas R, et al. Among authors: hsyu ph. Clin Pharmacokinet. 2016 Oct;55(10):1191-1204. doi: 10.1007/s40262-016-0391-6. Clin Pharmacokinet. 2016. PMID: 27113346 Review.

3

Renal transport of drugs: an overview of methodology with application to cimetidine.

Giacomini KM, Hsyu PH, Gisclon LG. Giacomini KM, et al. Among authors: hsyu ph. Pharm Res. 1988 Aug;5(8):465-71. doi: 10.1023/a:1015904905235. Pharm Res. 1988. PMID: 3072557 Review.

4

Population pharmacokinetic and pharmacodynamic analysis of bosutinib.

Hsyu PH, Mould DR, Abbas R, Amantea M. Hsyu PH, et al. Drug Metab Pharmacokinet. 2014;29(6):441-8. doi: 10.2133/dmpk.DMPK-13-RG-126. Epub 2014 Jun 10. Drug Metab Pharmacokinet. 2014. PMID: 24919837 Free article. Retracted. Clinical Trial.

5

Absolute Bioavailability of Bosutinib in Healthy Subjects From an Open-Label, Randomized, 2-Period Crossover Study.

Hsyu PH, Pignataro DS, Matschke K. Hsyu PH, et al. Clin Pharmacol Drug Dev. 2018 May;7(4):373-381. doi: 10.1002/cpdd.396. Epub 2017 Oct 23. Clin Pharmacol Drug Dev. 2018. PMID: 29058816 Clinical Trial.

6

Effect of aprepitant, a moderate CYP3A4 inhibitor, on bosutinib exposure in healthy subjects.

Hsyu PH, Pignataro DS, Matschke K. Hsyu PH, et al. Eur J Clin Pharmacol. 2017 Jan;73(1):49-56. doi: 10.1007/s00228-016-2108-z. Epub 2016 Oct 7. Eur J Clin Pharmacol. 2017. PMID: 27718000 Clinical Trial.

7

Oral ondansetron pharmacokinetics: the effect of chemotherapy.

Hsyu PH, Pritchard JF, Bozigian HP, Gooding AE, Griffin RH, Mitchell R, Bjurstrom T, Panella TL, Huang AT, Hansen LA. Hsyu PH, et al. J Clin Pharmacol. 1994 Jul;34(7):767-73. doi: 10.1002/j.1552-4604.1994.tb02038.x. J Clin Pharmacol. 1994. PMID: 7929872 Clinical Trial.

8

Pharmacokinetics of nelfinavir in subjects with hepatic impairment.

Damle B, Hewlett D Jr, Hsyu PH, Becker M, Petersen A. Damle B, et al. Among authors: hsyu ph. J Clin Pharmacol. 2006 Nov;46(11):1241-9. doi: 10.1177/0091270006292164. J Clin Pharmacol. 2006. PMID: 17050789 Clinical Trial.

9

Pharmacokinetic-pharmacodynamic relationship of bosutinib in patients with chronic phase chronic myeloid leukemia.

Hsyu PH, Mould DR, Upton RN, Amantea M. Hsyu PH, et al. Cancer Chemother Pharmacol. 2013 Jan;71(1):209-18. doi: 10.1007/s00280-012-1998-4. Epub 2012 Oct 16. Cancer Chemother Pharmacol. 2013. PMID: 23070145

10

Pharmacokinetic interactions between arbaprostil and aspirin in humans.

Hsyu PH, Cox JW, Pullen RH, Gee WL, Euler AR. Hsyu PH, et al. Biopharm Drug Dispos. 1989 Jul-Aug;10(4):411-22. doi: 10.1002/bdd.2510100408. Biopharm Drug Dispos. 1989. PMID: 2758104 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results